Three people who have attended a Biogen management meeting in Boston have tested positive for the COVID-19 coronavirus. The meeting […]
Researchers have used artificial intelligence to investigate network-based relationships between COVID-19 and Alzheimer’s disease, in the hope of informing therapeutic […]
Numerous datasets from historic clinical trials are being reviewed in the hope that existing drugs, that have already been cleared […]
Following the COVID-19 outbreak, which caused unprecedented disruption to the running of clinical trials, there has been an increasing interest […]
A recent study used previously identified viral interactions and human host proteins to apply a machine learning-based approach for connecting […]
At the time of writing, there have been 137 million cases and nearly 3 million deaths from COVID-19. Although some targets […]
In 2011 researchers, from The Institute of Cancer Research UK, created the largest, public, cancer drug discovery resource, known as […]
University of Southern California researchers have developed an AI framework to counter emergent mutations of the coronavirus and accelerate vaccine […]
Complex Innovative Design (CID) trials have the potential to increase efficiency and lower the costs of drug development. This type […]
New survey results from the Pistoia Alliance, the Quantum Economic Development Consortium (QED-C) and QuPharm show almost one third (31 […]
